RESEARCH PAPER
Evaluation of factors affecting survival of HIV/AIDS patients using Cox and extended Cox models
1
Student Research Committee, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
2
Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
3
Department of Biochemistry, Kermanshah University of Medical Sciences, Iran
4
Social Development and Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
Submission date: 2020-05-11
Final revision date: 2021-11-23
Acceptance date: 2022-02-11
Publication date: 2022-09-18
HIV & AIDS Review 2022;21(4):276-283
KEYWORDS
TOPICS
epidemiology - population studiessocio-medical aspects of HIV and AIDSeducational aspects of HIV and AIDSpatient-physician relationship
ABSTRACT
Introduction:
Acquired immune deficiency syndrome (AIDS) is a global viral disease that is increasing in populations with high-risk behaviors. Identifying factors prolonging survival of human immunodeficiency virus (HIV)-positive patients is imperative, and retrospective cohort studies with survival analysis approach are most applicable in research. The present study aims to determine an assessment of survival of HIV/AIDS-positive patients and its’ related factors.
Material and methods:
The present retrospective cohort study was conducted based on medical records of HIV-positive patients visiting Behavioral Diseases Counseling Centers in Kermanshah during 1996-2018. Cox and extended Cox regression models were applied for univariate and multivariate analyses. Data were analyzed using STATA-14.
Results:
The likelihood of one-, five-, and ten-year survival from the time of HIV diagnosis until AIDS stage was found as 0.87, 0.69, and 0.54, respectively, and the likelihood of one-, five-, and ten-year survival until AIDS-related death was estimated as 0.75, 0.44, and 0.21, respectively. The risk of disease progression to AIDS was greater in women and in patients with tuberculosis comorbidity. Receiving antiretroviral therapy reduced the risk of AIDS-related death by 3.9 times.
Conclusions:
The main correctable factors affecting the survival of HIV/ AIDS patients include early diagnosis, adherence to treatment, and receiving periodic services.
Acquired immune deficiency syndrome (AIDS) is a global viral disease that is increasing in populations with high-risk behaviors. Identifying factors prolonging survival of human immunodeficiency virus (HIV)-positive patients is imperative, and retrospective cohort studies with survival analysis approach are most applicable in research. The present study aims to determine an assessment of survival of HIV/AIDS-positive patients and its’ related factors.
Material and methods:
The present retrospective cohort study was conducted based on medical records of HIV-positive patients visiting Behavioral Diseases Counseling Centers in Kermanshah during 1996-2018. Cox and extended Cox regression models were applied for univariate and multivariate analyses. Data were analyzed using STATA-14.
Results:
The likelihood of one-, five-, and ten-year survival from the time of HIV diagnosis until AIDS stage was found as 0.87, 0.69, and 0.54, respectively, and the likelihood of one-, five-, and ten-year survival until AIDS-related death was estimated as 0.75, 0.44, and 0.21, respectively. The risk of disease progression to AIDS was greater in women and in patients with tuberculosis comorbidity. Receiving antiretroviral therapy reduced the risk of AIDS-related death by 3.9 times.
Conclusions:
The main correctable factors affecting the survival of HIV/ AIDS patients include early diagnosis, adherence to treatment, and receiving periodic services.
REFERENCES (34)
1.
Ministry of Health and Medical Education. The importance of AIDS. Available at: http://aidsbehdashtgovir/index.... 2019.
2.
Yavari P. Infection HIV and AIDS. In: Sharifi DH (ed.). Epidemiology of prevalent diseases in Iran. Volume 1: Communicable diseases. 1st ed. Tehran; 2013. p. 39.
3.
Hossein Hatami GY, Marjan Meshkati. Investigation of survival rate among HIV-positive individuals identified in Isfahan province, 1997-2013 (Iran). Qom Univ Med Sci 2017; 11: 66-75 [In Persian].
4.
UNAIDS/WHO. Global and regional epidemic HIV 2019 [updated July 2019]. Available at: https://www.who.int/hiv/data/2....
5.
Nasirian M, Doroudi F, Gooya MM, Sedaghat A, Haghdoost AA. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci 2012; 12: 81-87.
6.
Ministry of Health and Medical Education. Latest statistics on HIV infection in the Islamic Republic of Iran by the end of the year 2019. Tehran: Ministry of Health and Medical Education; 2019.
7.
HIV/AIDS Infectious Disease Control Center Newsletter. HIV/AIDS Infectious Disease. 1395; Summer (HIV/AIDS Infectious Disease): 8.
10.
Tadesse K, Haile F, Hiruy N. Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, Northern Ethiopia: a retrospective cohort study. PLoS One 2014; 9: e87392.
11.
Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019; 393: 2428-2438.
12.
Trickey A, May MT, Vehreschild JJ, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017; 4: e349-e356.
13.
Mirzaei M, Poorolajal J, Khazaei S, Saatchi M. Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997–2011). Int J STD AIDS 2013; 24: 859-866.
14.
Kee MK, Lee JH, Kim EJ, et al. Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis 2009; 9: 128.
15.
Karimi N, Safari M, Roshanaei G, Poorolajal J. Determining of factors affecting on mortality of AIDS patients by using extended Cox model. J Arak Uni Med Sci 2018; 21: 76-87.
16.
Centers for Disease Control and Prevention (CDC). HIV surveillance report, 2017. Vol 29. 2018. Available at: https://www.cdc.gov/hiv/pdf/li....
17.
Lieb S, Fallon SJ, Friedman SR, et al. Statewide estimation of racial/ethnic populations of men who have sex with men in the US. Public Health Rep 2011; 126: 60-72.
18.
Frank TD, Carter A, Jahagirdar D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV 2019; 6: e831-e859.
19.
Joint United Nations Programme on HIV/AIDS (UNAIDS). Ending AIDS. Progress towards the 90-90-90 targets. 2017. Available at: https://www.unaids.org/sites/d....
20.
Kulkarni MB, Bhalerao MM. Effect of ante retroviral therapy on cd4 count in people living with HIV/AIDS. Indian Journal of Applied Research 2019; 9.
21.
Granich R, Gupta S. 90-90-90 HIV targets: implications for HIV-associated tuberculosis. Curr Opin HIV AIDS 2018; 13: 528-537.
22.
Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS statistics – Fact sheet. 2021. Available at: https://www.unaids.org/sites/d....
23.
Lolekha R, Boonsuk S, Plipat T, et al. Elimination of mother-to-child transmission of HIV – Thailand. MMWR Morb Mortal Wkly Rep 2016; 65: 562-566.
24.
Guo HS, Feng XX, Zhang Q, et al. Survival status and influencing factors of HIV/AIDS cases in Liuzhou, 2008-2018. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 2098-2103.
25.
Marzán-Rodríguez M, Zavala Segarra DE, Valverde JCO, Varas-Díaz N, De León SM, Acevedo-Díaz E. Survival analysis in people diagnosed with HIV/AIDS in Puerto Rico. Rev Puertoriq Med Salud Publica 2018; 66: 8-14.
26.
Liu Z, Zhou N, Bai J, Guo Y, Yu M. Analysis of survival and influencing factors of HIV/AIDS patients in Tianjin, 2004-2014. Zhonghua Liu Xing Bing Xue Za Zhi 2017; 38: 369-373.
27.
Aung ZZ, Saw YM, Saw TN, et al. Survival rate and mortality risk factors among TBHIV co-infected patients at an HIV-specialist hospital in Myanmar: a 12-year retrospective follow-up study. Int J Infect Dis 2019; 80: 10-15.
28.
Mirzaei M, Farhadian M, Poorolajal J, Kazerooni PA, Tayeri K, Mohammadi Y. Life expectancy of HIV-positive patients after diagnosis in Iran from 1986 to 2016: a retrospective cohort study at national and sub-national levels. Epidemiol Health 2018; 40: e2018053.
29.
Sabermahani A, Barouni M, Seyedin H, Aryankhesal A. Provincial human development index, a guide for efficiency level analysis: the case of Iran. Iranian J Public Health 2013; 42: 149.
30.
Likatavicius G, Van de Laar M. HIV and AIDS in the European Union, 2011. Euro Surveill 2012; 17: 20329.
31.
Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 1447-1450.
32.
Girardi E, Sabin CA, Monforte A. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46: S3-S8.
33.
Poorolajal J, Molaeipoor L, Mohraz M, et al. Predictors of progression to AIDS and mortality post-HIV infection: a long-term retrospective cohort study. AIDS Care 2015; 27: 1205-1212.
34.
Zenner D, Abubakar I, Conti S, et al. Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland. Thorax 2015; 70: 566-573.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
